OncoRes Medical Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $19.8M

  • Investors
  • 19

OncoRes Medical General Information

Description

Developer of an intraoperative imaging tool designed to upgrade the standard of care in breast cancer surgery. The company's technology utilizes a novel combination of optical coherence tomography imaging, improving surgical accuracy and reducing complication rates and intraoperative complications, enabling surgeons to identify a tumor and healthy tissue.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 24 Leura Street
  • Suite 5
  • Nedlands, Western Australia 6009
  • Australia
+61 0408
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 24 Leura Street
  • Suite 5
  • Nedlands, Western Australia 6009
  • Australia
+61 0408

OncoRes Medical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoRes Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC 12-Feb-2026 $19.8M Completed Generating Revenue
13. Accelerator/Incubator 23-Dec-2024 Completed Pre-Clinical Trials
12. Accelerator/Incubator 01-Jan-2024 Completed Pre-Clinical Trials
11. Grant 18-Jul-2023 Completed Pre-Clinical Trials
10. Grant 01-Jan-2023 Completed Pre-Clinical Trials
9. Grant 18-May-2022 Completed Pre-Clinical Trials
8. Later Stage VC (Series A2) 18-May-2022 Completed Pre-Clinical Trials
7. Later Stage VC (Series B) 05-May-2021 Completed Pre-Clinical Trials
6. Grant 22-Jan-2021 $150K $4.59M Completed Pre-Clinical Trials
5. Accelerator/Incubator 29-Oct-2020 $110K $4.59M Completed Pre-Clinical Trials
To view OncoRes Medical’s complete valuation and funding history, request access »

OncoRes Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Preference
To view OncoRes Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

OncoRes Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an intraoperative imaging tool designed to upgrade the standard of care in breast cancer surgery. The compa
Diagnostic Equipment
Nedlands, Australia
40 As of 2026

Bangalore, India
 

Philadelphia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

OncoRes Medical Competitors (7)

One of OncoRes Medical’s 7 competitors is Niramai, a Venture Capital-Backed company based in Bangalore, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Niramai Venture Capital-Backed Bangalore, India
UE LifeSciences Venture Capital-Backed Philadelphia, PA
Ferronova Venture Capital-Backed Prospect, Australia
iCAD Corporate Backed or Acquired Nashua, NH
Mauna Kea Technologies Formerly VC-backed Paris, France
You’re viewing 5 of 7 competitors. Get the full list »

OncoRes Medical Patents

OncoRes Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2026906522-A0 System system and method for tracking relative motion between an imaging device and a sample Pending 23-Jul-2026
AU-2026204970-B1 Method, system and apparatus for determining orientation data Active 25-Jun-2026
AU-2025903337-A0 Method, system and apparatus for determining orientation data Pending 30-Jul-2025
AU-2025903169-A0 System and method for tracking relative motion between an imaging device and a sample Pending 22-Jul-2025
AU-2025902293-A0 Method, system and apparatus for determining orientation data Inactive 06-Jun-2025
To view OncoRes Medical’s complete patent history, request access »

OncoRes Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OncoRes Medical Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
Morgans Financial Corporation Minority
Radar Ventures (Australia) Venture Capital Minority
The Table Club Corporation Minority
ANDHealth Accelerator/Incubator
WA Health, Government of Western Australia Government
You’re viewing 5 of 19 investors. Get the full list »

OncoRes Medical FAQs

  • When was OncoRes Medical founded?

    OncoRes Medical was founded in 2016.

  • Where is OncoRes Medical headquartered?

    OncoRes Medical is headquartered in Nedlands, Australia.

  • What is the size of OncoRes Medical?

    OncoRes Medical has 40 total employees.

  • What industry is OncoRes Medical in?

    OncoRes Medical’s primary industry is Diagnostic Equipment.

  • Is OncoRes Medical a private or public company?

    OncoRes Medical is a Private company.

  • What is the current valuation of OncoRes Medical?

    The current valuation of OncoRes Medical is .

  • What is OncoRes Medical’s current revenue?

    The current revenue for OncoRes Medical is .

  • How much funding has OncoRes Medical raised over time?

    OncoRes Medical has raised $35.6M.

  • Who are OncoRes Medical’s investors?

    Morgans Financial, Radar Ventures (Australia), The Table Club, ANDHealth, and WA Health, Government of Western Australia are 5 of 19 investors who have invested in OncoRes Medical.

  • Who are OncoRes Medical’s competitors?

    Niramai, UE LifeSciences, Ferronova, iCAD, and Mauna Kea Technologies are some of the 7 competitors of OncoRes Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process